Drug Information Journal - March 2009 - (Page 129) A Pharmaceutical Alliance in Medical Information MEDICAL INFORMATION 129 lead to overall improvements in the processes involved in working together. It is important to maintain the team focus of working toward a common goal (14). Alliances evolve with new business opportunities. Medical information departments need to follow and be adaptive to fast-paced change in the pharmaceutical world. Acknowledgment—We would like to acknowledge Louise Dambrauskas, Jessica Bland, Blanca Chou, and the staff at the Information Resource Center, Otsuka America Pharmaceutical, Inc, for their research expertise and reference assistance. REFERENCES 1. Stuart TE. Network positions and propensities to collaborate: an investigation of strategic alliance formation in a high technology industry. Admin Sci Q. 1998;43:668–698. 2. Hall J. A decade (and 1/2) of deals. Pharm Exec Suppl. 2004(October). 3. Richardson J, Evangelista E. Becoming partners of choice. Pharm Exec. 2002;22(1 1):12–16. 4. Mitsuhashi H. Uncertainty in selecting alliance partners: the three reduction mechanisms and alliance formation process. Int J Org Anal. 2002; 10(2):109–1 33. 5. Blumberg L. How to engage in a strategic outsourcing relationship. Pharm Tech North Am. 2002;26(7):74–80. 6. Tyebjee T, Hardin J. Biotech-pharma alliances: strategies, structures and financing. J Commerc Biotechnol. 2004;10(4):329–339. 7. From biotech to pharma: biotechnology companies are full of innovation; pharmaceutical companies are willing to pay big bucks for it, and together they aim to bring better drugs to market. Med Ad News. 2004;23(8):1(5). 8. Lam MD. Why alliances fail. Pharm Exec. 2004; 24(6):56–66. 9. Cutting edge information. Bus Devel Spend Structure. 2005:155. 10. Culley CF, Hoffman KH, Slavik R. Merger mania: impact on the medical information department. Drug Inf J. 2000;34:1 163–1 168. 1 Curran CF, Sundar MN, Deiters AJ. Drug informa1. tion coordination for a copromoted product. Drug Inf J. 2000;34:97–101. 12. Price G. An introduction to medical affairs. In Fletcher AJ, Edwards LO, Fox AW, and Stonier PD, eds. Principles and Practice of Pharmaceutical Medicine. New York: John Wiley; 2002:365–369. 1 PhRMA. PhRMA guiding principles. Available 3. at: www.phrma.org/publications/policy_papers /phrma_dtc_guiding_principles. 14. Finn TM, McCamey DA. P&G’s guide to successful partnerships. Pharm Exec. 2002;22(1):54–60. Yen Krystal Miao has disclosed that she is a stock shareholder in Bristol-Myers Squibb. Lisa Kochan Lomma has disclosed that she has worked as a contractor for Otsuka America Pharmaceuticals, Inc. Andrei Pikalov, Richard Whitehead, and Quynh-Van N. D. Tran report no conflicts to disclose. Drug Information Journal http://www.phrma.org/publications/policy_papers/phrma_dtc_guiding_principles
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.